EAT vs IONS · P/E 15, rev $5.81B vs rev $514.0M
Brinker International Inc (EAT) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Brinker International Inc (EAT) is a restaurants company listed on NYSE.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported EAT revenue for 2026-06-24 was $5.81B. Net income was $487.0M. Revenue was up 7.9% from 2025-06-25 to 2026-06-24. EAT currently screens at market cap $6.81B and trailing P/E 15.5.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
EAT currently screens at market cap $6.81B and trailing P/E 15.5. IONS currently screens at market cap $12.28B.
Not investment advice. Open the EAT and IONS stock pages for the full models.
Not investment advice.